FBP1 and hepatocellular carcinoma: Some HDACI is protective against HCC via correcting aberrant acetylated activity of fructose-1,6-bisphosphatase (FBP1) gene, thus, suppressing glucose metabolism and HCC cell growth in vitro and tumor growth in mice (Yang et al., 2017).